MTOR - mechanistic target of rapamycin kinase Gene
Species: Macaca mulatta
Gene Type: protein coding
Gene ID: 106992736
About MTOR
Primary_assembly 1: 213,196,826-213,345,451 forward strand.Mmul_10:CM014336.1
This gene has 3 transcripts (splice variants), 217 orthologues and 5 paralogues.
MTOR Products (3)
| mRNA | Protein | Name |
|---|---|---|
| XM_015111168.2 | XP_014966654.1 | serine/threonine-protein kinase mTOR |
| XM_015111238.2 | XP_014966724.1 | serine/threonine-protein kinase mTOR |
| XM_015111100.2 | XP_014966586.1 | serine/threonine-protein kinase mTOR |
MTOR Protein Structure
TEL1
TEL1: COG5032 (362 - 2548)
HEAT
HEAT: sd00044 (654 - 680)
HEAT
HEAT: sd00044 (690 - 720)
HEAT
HEAT: sd00044 (728 - 758)
HEAT
HEAT: sd00044 (771 - 804)
HEAT
HEAT: sd00044 (816 - 846)
HEAT
HEAT: sd00044 (954 - 980)
HEAT
HEAT: sd00044 (992 - 1020)
HEAT
HEAT: sd00044 (1032 - 1061)
HEAT
HEAT: sd00044 (1072 - 1098)
HEAT
HEAT: sd00044 (1110 - 1141)
HEAT
HEAT: sd00044 (1153 - 1179)
- 0
- 400
- 800
- 1200
- 1600
- 2000
- 2400
- 2549 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
serine/threonine-protein kinase mTOR |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(32)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-10219 | Rapamycin | Inhibitor | 99.94% | Yes |
| HY-B0627 | Metformin | Inhibitor | 99.98% | Yes |
| HY-10218 | Everolimus | Inhibitor | 99.85% | Yes |
| HY-17471A | Metformin hydrochloride | Inhibitor | 99.98% | Yes |
| HY-Y0252 | L-Proline | Activator | 99.75% | Unkown |
| HY-N0486 | L-Leucine | Activator | 99.79% | Unkown |
| HY-50910 | Temsirolimus | Inhibitor | 99.56% | Yes |
| HY-B0298A | Clemastine fumarate | Activator | 99.96% | Yes |
| HY-16397A | Phenformin hydrochloride | Inhibitor | 99.64% | Unkown |
| HY-W019894 | Manganese chloride | Activator | 99.1% | Unkown |
| HY-16397 | Phenformin | Inhibitor | 98.02% | Unkown |
| HY-N0281 | Daphnetin | Inhibitor | 99.77% | Unkown |
| HY-N0390R | L-Glutamine (Standard) | Inhibitor | 98.59% | Unkown |
| HY-10219R | Rapamycin (Standard) | Inhibitor | 98.98% | Unkown |
| HY-B0766 | Bicyclol | 99.91% | Unkown | |
| HY-17471AR | Metformin hydrochloride (Standard) | Inhibitor | 99.97% | Unkown |
| HY-14668 | Lomitapide mesylate | Inhibitor | 99.61% | Yes |
| HY-B0319 | Tioconazole | Inhibitor | 99.90% | Unkown |
| HY-B0298 | Clemastine | Activator | 99.26% | Yes |
| HY-N6951 | Guaiazulene | Inhibitor | 99.08% | Unkown |
| HY-10218R | Everolimus (Standard) | Inhibitor | 99.27% | Unkown |
| HY-128932 | Cefminox sodium | 99.83% | Unkown | |
| HY-B0168B | Levomilnacipran hydrochloride | Activator | 99.95% | Unkown |
| HY-B0921 | Succinylsulfathiazole | Inhibitor | 99.22% | Unkown |
| HY-B0725A | Doxepin | 99.66% | Yes | |
| HY-15960 | PWT-33597 free base | Inhibitor | / | Unkown |
| HY-15960A | PWT-33597 | Inhibitor | / | Unkown |
| HY-B1232A | Metyrapone Tartrate | Modulator | / | Unkown |
| HY-14794A | Levomilnacipran | Activator | / | Unkown |
| HY-B0298AR | Clemastine fumarate (Standard) | Activator | / | Unkown |
| HY-16397R | Phenformin (Standard) | Inhibitor | / | Unkown |
| HY-16397AR | Phenformin hydrochloride (Standard) | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-P9933 | Dinutuximab | Inhibitor | ≥99.0% | Unkown |
Clinical Phase
Bioactive Molecules
(45)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Phase |
|---|---|---|---|---|
| HY-131686 | Ganglioside GT1b (bovine) ammonium | Activator | 98.0% | Phase 4 |
| HY-B0627A | Metformin (glycinate) | Inhibitor | / | Phase 4 |
| HY-50673 | Dactolisib | Inhibitor | 99.94% | Phase 3 |
| HY-10681 | Gedatolisib | Inhibitor | 99.89% | Phase 3 |
| HY-19962 | Paxalisib | Inhibitor | 99.51% | Phase 3 |
| HY-15174 | Dactolisib Tosylate | Inhibitor | 99.87% | Phase 3 |
| HY-139142B | Simufilam hydrochloride | Inhibitor | 99.85% | Phase 3 |
| HY-139142 | Simufilam | Inhibitor | 99.78% | Phase 3 |
| HY-16728 | Rapastinel | Activator | 99.78% | Phase 3 |
| HY-B1787 | Sulindac sulfone | Inhibitor | 98.10% | Phase 3 |
| HY-139142A | Simufilam dihydrochloride | Inhibitor | / | Phase 3 |
| HY-50876 | Daporinad | Inhibitor | 99.91% | Phase 2 |
| HY-13328 | Sapanisertib | Inhibitor | 99.88% | Phase 2 |
| HY-N0112 | Dihydromyricetin | Inhibitor | 99.73% | Phase 2 |
| HY-139609 | Camonsertib | Inhibitor | 99.99% | Phase 2 |
| HY-15177 | PF-04691502 | Inhibitor | 99.33% | Phase 2 |
| HY-N9481 | Lipoteichoic acid | Inhibitor | / | Phase 2 |
| HY-12513 | Samotolisib | Inhibitor | 98.85% | Phase 2 |
| HY-13246 | Apitolisib | Inhibitor | 99.29% | Phase 2 |
| HY-12868 | Bimiralisib | Inhibitor | 98.62% | Phase 2 |
| HY-13334A | BGT226 | Inhibitor | 99.85% | Phase 2 |
| HY-10423 | OSI-027 | Inhibitor | 99.95% | Phase 2 |
| HY-16956 | Onatasertib | Inhibitor | 99.47% | Phase 2 |
| HY-15900 | Voxtalisib | Inhibitor | 99.82% | Phase 2 |
| HY-13334 | BGT226 maleate | Inhibitor | 99.92% | Phase 2 |
| HY-109179 | Itacnosertib | Inhibitor | 99.06% | Phase 2 |
| HY-13691 | MKC-1 | Inhibitor | 99.78% | Phase 2 |
| HY-13610 | N1,N11-Diethylnorspermine | Inhibitor | / | Phase 2 |
| HY-10358 | MK-2206 dihydrochloride | Inhibitor | 99.99% | Phase 1 |
| HY-10422 | AZD-8055 | Inhibitor | 99.60% | Phase 1 |
| HY-10297 | Omipalisib | Inhibitor | 99.94% | Phase 1 |
| HY-132168 | RMC-5552 | Inhibitor | 99.94% | Phase 1 |
| HY-16962 | CC-115 | Inhibitor | 99.10% | Phase 1 |
| HY-16585 | VS-5584 | Inhibitor | 98.71% | Phase 1 |
| HY-14774 | Monepantel | Inhibitor | 99.98% | Phase 1 |
| HY-12036 | GSK1059615 | Inhibitor | 99.76% | Phase 1 |
| HY-16962A | CC-115 hydrochloride | Inhibitor | 98.01% | Phase 1 |
| HY-14581 | Palomid 529 | Inhibitor | 99.37% | Phase 1 |
| HY-11080 | PKI-179 | Inhibitor | 98.0% | Phase 1 |
| HY-15248 | GDC-0349 | Inhibitor | 99.10% | Phase 1 |
| HY-126077 | MTI-31 | Inhibitor | 99.98% | Phase 1 |
| HY-124036 | DS-7423 | Inhibitor | 99.83% | Phase 1 |
| HY-137315 | TML-6 | Inhibitor | 98.34% | Phase 1 |
| HY-11080A | PKI-179 hydrochloride | Inhibitor | 99.66% | Phase 1 |
| HY-15691A | PF-4455242 hydrochloride | Activator | 99.01% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(484)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-10071 | Y-27632 | Inhibitor | 99.91% | Unkown |
| HY-B0795 | MHY1485 | Activator | 99.93% | Unkown |
| HY-13003 | Torin 1 | Inhibitor | 99.28% | Unkown |
| HY-N0171A | Beta-Sitosterol (purity>98%) | Agonist | 99.74% | Unkown |
| HY-N0390S1 | L-Glutamine-13C5 | Inhibitor | 99.93% | Unkown |
| HY-N0109 | Salidroside | Activator | 99.88% | Unkown |
| HY-13002 | Torin 2 | Inhibitor | 99.69% | Unkown |
| HY-112537 | D-Glucose 6-phosphate | Activator | 99.90% | Unkown |
| HY-10115 | PI-103 | Inhibitor | 99.82% | Unkown |
| HY-122022 | JR-AB2-011 | Inhibitor | 98.15% | Unkown |
| HY-124719 | hSMG-1 inhibitor 11j | Inhibitor | 99.82% | Unkown |
| HY-15247 | Vistusertib | Inhibitor | 99.70% | Unkown |
| HY-P1410B | D-GsMTx4 | Inhibitor | 99.44% | Unkown |
| HY-N0189 | Aloe emodin | Inhibitor | 98.32% | Unkown |
| HY-10474 | Torkinib | Inhibitor | 99.03% | Unkown |
| HY-N0143 | Phlorizin | Inhibitor | 99.93% | Unkown |
| HY-13610A | N1,N11-Diethylnorspermine tetrahydrochloride | Inhibitor | 99.82% | Unkown |
| HY-100542 | D-α-Hydroxyglutaric acid disodium | Inhibitor | 98.0% | Unkown |
| HY-108232 | MK-2206 | Inhibitor | 99.72% | Unkown |
| HY-N0270 | Ononin | Inhibitor | 99.97% | Unkown |
| HY-N0022 | Isoacteoside | Inhibitor | 99.73% | Unkown |
| HY-W012722 | 4-Methyl-2-oxopentanoic acid | Inhibitor | 99.51% | Unkown |
| HY-U00434 | 3BDO | Activator | 99.93% | Unkown |
| HY-111373 | RapaLink-1 | Inhibitor | 99.65% | Unkown |
| HY-N0047 | Polyphyllin I | Inhibitor | 99.91% | Unkown |
| HY-114384 | Mefluleucine | Activator | 98.0% | Unkown |
| HY-N0787 | Cryptochlorogenic acid | Inhibitor | 99.87% | Unkown |
| HY-106591A | 4-Vinylcyclohexene dioxide | Activator | 98.57% | Unkown |
| HY-N0486S9 | L-Leucine-d3 | Activator | 99.98% | Unkown |
| HY-155864 | AJ2-30 | Inhibitor | 99.85% | Unkown |
| HY-N0390S8 | L-Glutamine-15N2 | Inhibitor | 99.95% | Unkown |
| HY-155747 | FDW028 | Inhibitor | 99.51% | Unkown |
| HY-N0390S | L-Glutamine-15N | Inhibitor | 99.6% | Unkown |
| HY-124798 | Rheb inhibitor NR1 | Inhibitor | 99.26% | Unkown |
| HY-W011927 | 4,4'-Sulfonyldiphenol | Agonist | 99.81% | Unkown |
| HY-P1410C | D-GsMTx4 TFA | Inhibitor | 99.89% | Unkown |
| HY-116522 | AR420626 | 98.40% | Unkown | |
| HY-124760 | hSMG-1 inhibitor 11e | Inhibitor | 99.94% | Unkown |
| HY-50710 | KU-0063794 | Inhibitor | 99.67% | Unkown |
| HY-134508 | C24-Ceramide | Activator | 99.92% | Unkown |
| HY-N0390S9 | L-Glutamine-15N-1 | Inhibitor | 98.0% | Unkown |
| HY-113038 | D-α-Hydroxyglutaric acid | Inhibitor | 98.0% | Unkown |
| HY-W142080 | α-Methyl-DL-tryptophan | Inhibitor | 99.99% | Unkown |
| HY-N0837 | Veratramine | Inhibitor | 99.88% | Unkown |
| HY-155033 | SSI-4 | Inhibitor | 99.99% | Unkown |
| HY-N0390S2 | L-Glutamine-d5 | Inhibitor | 99.79% | Unkown |
| HY-N1462 | Atractyloside potassium salt | Inhibitor | 99.93% | Unkown |
| HY-128483 | Fusaric acid | Inhibitor | 99.94% | Unkown |
| HY-W592871 | 10-Hydroxy-2-decenoic acid | 99.93% | Unkown | |
| HY-N0486S1 | L-Leucine-13C | Activator | 99.90% | Unkown |
| HY-Y0396 | N-Hydroxyphthalimide | Inhibitor | 99.89% | Unkown |
| HY-114384B | Mefluleucine hydrochloride | Activator | 98.0% | Unkown |
| HY-N0876 | Arenobufagin | 99.82% | Unkown | |
| HY-N6996 | Methyl Eugenol | Inhibitor | 99.79% | Unkown |
| HY-N0404 | Sinigrin | Inhibitor | 99.97% | Unkown |
| HY-N0486S8 | L-Leucine-13C6,15N | Activator | 99.90% | Unkown |
| HY-N0819 | Raddeanin A | Inhibitor | 98.68% | Unkown |
| HY-N1437 | Hydroxycitric acid | Activator | 99.95% | Unkown |
| HY-N6626 | Pyraclostrobin | 99.91% | Unkown | |
| HY-112537S1 | D-Glucose 6-Phosphate-13C6 (disodium xhydrate) | Activator | 99.6% | Unkown |
| HY-N1255 | Scoulerine | Inhibitor | 99.99% | Unkown |
| HY-N6602 | α-Solanine | Inhibitor | 99.89% | Unkown |
| HY-50908 | Ridaforolimus | Inhibitor | 99.75% | Unkown |
| HY-N0447 | 8-Gingerol | Modulator | 99.82% | Unkown |
| HY-N0486S2 | L-Leucine-13C6 | Activator | 99.64% | Unkown |
| HY-15521 | ETP-46464 | Inhibitor | 99.54% | Unkown |
| HY-168555 | YJ1206 | Activator | 97.26% | Unkown |
| HY-10044 | WYE-132 | Inhibitor | 99.90% | Unkown |
| HY-100398 | PF-04979064 | Inhibitor | 99.93% | Unkown |
| HY-12763 | GNE-317 | Inhibitor | 98.76% | Unkown |
| HY-10372 | PP121 | Inhibitor | 99.51% | Unkown |
| HY-N0390S6 | L-Glutamine-13C5,15N2 | Inhibitor | 98.0% | Unkown |
| HY-N1677 | 2,6-Dimethoxy-1,4-benzoquinone | 98.72% | Unkown | |
| HY-110228 | Metformin-d6 hydrochloride | Inhibitor | 99.98% | Unkown |
| HY-W016412 | Coenzyme Q0 | Inhibitor | 99.79% | Unkown |
| HY-N0616 | Trifolirhizin | Activator | 98.37% | Unkown |
| HY-115449 | Chromeceptin | p53 Inhibitor | 99.80% | Unkown |
| HY-10683 | PKI-402 | Inhibitor | 99.17% | Unkown |
| HY-13431 | KU-0060648 | Inhibitor | 99.87% | Unkown |
| HY-10115A | PI-103 Hydrochloride | Inhibitor | 98.06% | Unkown |
| HY-N0657 | Pinoresinol Diglucoside | 99.84% | Unkown | |
| HY-N6950 | Hederacolchiside A1 | Modulator | 98.28% | Unkown |
| HY-134904 | RMC-6272 | Inhibitor | 97.42% | Unkown |
| HY-18353 | mTOR inhibitor-3 | Inhibitor | 99.79% | Unkown |
| HY-N0712 | Typhaneoside | Activator | 99.74% | Unkown |
| HY-139534 | ARI-1 | Inhibitor | 99.16% | Unkown |
| HY-N0885 | Telocinobufagin | Inhibitor | 99.93% | Unkown |
| HY-N2541 | Gymnemic acid I | Inhibitor | 98.84% | Unkown |
| HY-N7400 | Phaseoloidin | Activator | 99.92% | Unkown |
| HY-W130610 | Stearamide | Activator | 97.0% | Unkown |
| HY-N0735 | Phellodendrine chloride | Agonist | 99.68% | Unkown |
| HY-156671 | RMC-4998 | Inhibitor | 99.31% | Unkown |
| HY-146751 | PI3K/Akt/mTOR-IN-2 | Inhibitor | 99.93% | Unkown |
| HY-N0107 | Cyclovirobuxine D | Inhibitor | 99.70% | Unkown |
| HY-N0381 | Maackiain | Inhibitor | 99.83% | Unkown |
| HY-W011927S | 4,4'-Sulfonyldiphenol-d8 | Agonist | 99.21% | Unkown |
| HY-N0486S | L-Leucine-d10 | Activator | 99.0% | Unkown |
| HY-100222 | CZ415 | Inhibitor | 98.39% | Unkown |
| HY-159480 | AD1058 | Inhibitor | 98.11% | Unkown |
| HY-N0910 | Notoginsenoside Ft1 | Inhibitor | 99.49% | Unkown |
| HY-12808 | STF-118804 | Inhibitor | 99.72% | Unkown |
| HY-N4177 | Rubrofusarin gentiobioside | Inhibitor | 99.04% | Unkown |
| HY-N0486S3 | L-Leucine-15N | Activator | 98.0% | Unkown |
| HY-N0656A | (+)-Usnic acid | Inhibitor | 99.64% | Unkown |
| HY-174406 | MT-125 | Activator | 98.73% | Unkown |
| HY-P1823 | C-Reactive Protein (CRP) (174-185) | Modulator | 99.88% | Unkown |
| HY-N0695 | Schisantherin B | Inhibitor | 99.75% | Unkown |
| HY-N6983 | Licoricesaponin G2 | 99.87% | Unkown | |
| HY-10811 | GNE-493 | Inhibitor | 99.81% | Unkown |
| HY-111508 | PI3K/mTOR Inhibitor-2 | Inhibitor | 99.10% | Unkown |
| HY-N0390S5 | L-Glutamine-1-13C | Inhibitor | 98.0% | Unkown |
| HY-N3651 | Curzerenone | Inhibitor | 98.55% | Unkown |
| HY-19763 | Ifupinostat | Inhibitor | 99.30% | Unkown |
| HY-N3677 | Dammarenediol II | Inhibitor | 99.81% | Unkown |
| HY-15272 | WAY-600 | Inhibitor | 99.86% | Unkown |
| HY-12034 | WYE-354 | Inhibitor | 98.03% | Unkown |
| HY-114414 | HDACs/mTOR Inhibitor 1 | Inhibitor | 98.10% | Unkown |
| HY-112914 | mTOR inhibitor-1 | Inhibitor | 98.82% | Unkown |
| HY-112440 | HZX-02-059 | Inhibitor | 99.40% | Unkown |
| HY-N0109R | Salidroside (Standard) | Activator | 99.82% | Unkown |
| HY-N0008 | Orcinol glucoside | Activator | 99.40% | Unkown |
| HY-N0914 | Ajugol | Inhibitor | 99.80% | Unkown |
| HY-100026 | PQR620 | Inhibitor | 98.01% | Unkown |
| HY-136660 | PQR626 | Inhibitor | 99.96% | Unkown |
| HY-N6843 | Arnicolide D | Inhibitor | 99.69% | Unkown |
| HY-N2217 | Rotundic acid | Inhibitor | 99.41% | Unkown |
| HY-16441 | Tegafur-gimeracil-oteracil potassium | Inhibitor | 99.96% | Unkown |
| HY-162143 | SKI-349 | Inhibitor | 99.48% | Unkown |
| HY-174406A | MT-125 free base | Activator | 98.67% | Unkown |
| HY-W142432 | Perfluoroundecanoic acid | Activator | 99.85% | Unkown |
| HY-100470 | NSC781406 | Inhibitor | 99.97% | Unkown |
| HY-107365 | PQR530 | Inhibitor | 99.98% | Unkown |
| HY-10219G | Rapamycin (GMP) | Inhibitor | / | Unkown |
| HY-101955 | (2S,6S)-Hydroxynorketamine hydrochloride | Activator | 99.30% | Unkown |
| HY-W338584 | Hydroxycitric acid tripotassium | Activator | 98.0% | Unkown |
| HY-N1163 | Tetrahydroalstonine | Activator | 99.88% | Unkown |
| HY-13806 | XL388 | Inhibitor | 99.57% | Unkown |
| HY-11095 | NPS 2390 | Inhibitor | 99.90% | Unkown |
| HY-11042 | GNE-477 | Inhibitor | 98.75% | Unkown |
| HY-131344 | mTOR inhibitor-8 | Inhibitor | 98.14% | Unkown |
| HY-128333 | PI3K/mTOR Inhibitor-4 | Inhibitor | 97.04% | Unkown |
| HY-118712 | WYE-23 | Inhibitor | 99.24% | Unkown |
| HY-16728B | Rapastinel Trifluoroacetate | Activator | 98.0% | Unkown |
| HY-N2445 | Flavokawain C | Activator | 99.79% | Unkown |
| HY-W749694 | Cannflavin B | Inhibitor | 98.36% | Unkown |
| HY-N1050 | Zederone | Inhibitor | 99.61% | Unkown |
| HY-178164 | HBS-101 | Inhibitor | 99.59% | Unkown |
| HY-137175 | TMBIM6 antagonist-1 | Antagonist | 98.92% | Unkown |
| HY-163198 | ASCT2-IN-1 | Inhibitor | 98.21% | Unkown |
| HY-109046 | Tulrampator | 99.39% | Unkown | |
| HY-Y1177 | Diphenyl disulfide | Inhibitor | 99.96% | Unkown |
| HY-W058849 | MT 63-78 | Inhibitor | 98.11% | Unkown |
| HY-N3307 | (+)-Medioresinol | Agonist | 99.13% | Unkown |
| HY-N3000 | 6-Methoxydihydrosanguinarine | Inhibitor | 99.88% | Unkown |
| HY-157169 | IBL-302 | Inhibitor | 95.49% | Unkown |
| HY-10219S | Rapamycin-d3 | Inhibitor | 95.92% | Unkown |
| HY-151622 | PI3K/mTOR Inhibitor-11 | Inhibitor | 99.65% | Unkown |
| HY-179578 | SU212 | Inhibitor | / | Unkown |
| HY-N4315 | Pomiferin | Inhibitor | 98.01% | Unkown |
| HY-162382 | KTC1101 | Inhibitor | 98.09% | Unkown |
| HY-N4247 | Kuwanon G | Inhibitor | 99.45% | Unkown |
| HY-10218S | Everolimus-d4 | Inhibitor | 98.74% | Unkown |
| HY-10681R | Gedatolisib (Standard) | Inhibitor | 97.70% | Unkown |
| HY-143510 | RMC-4627 | 99.20% | Unkown | |
| HY-N2590 | Lupenone | 99.74% | Unkown | |
| HY-125927 | 8-Aminoadenosine | Inhibitor | 99.05% | Unkown |
| HY-122665 | HTH-01-091 | Inhibitor | 99.81% | Unkown |
| HY-W348485 | WRX606 | Inhibitor | 95.65% | Unkown |
| HY-175646 | AGPAT4-IN-1 | Inhibitor | 99.04% | Unkown |
| HY-130687A | Psicose | Activator | 99.90% | Unkown |
| HY-10219GL | Rapamycin (GMP Like) | Inhibitor | / | Unkown |
| HY-134903 | (32-Carbonyl)-RMC-5552 | Inhibitor | 95.41% | Unkown |
| HY-173119 | SKLB-D18 | Inhibitor | 98.06% | Unkown |
| HY-107363 | FT-1518 | Inhibitor | 98.62% | Unkown |
| HY-132902 | DEPTOR-IN-1 | Inhibitor | 98.13% | Unkown |
| HY-109179A | Itacnosertib hydrochloride | Inhibitor | 99.43% | Unkown |
| HY-153789 | PI5P4Kγ-IN-1 | Activator | 98.82% | Unkown |
| HY-163199 | ASCT2-IN-2 | Inhibitor | 99.10% | Unkown |
| HY-N0390S4 | L-Glutamine-5-13C | Inhibitor | 98.0% | Unkown |
| HY-N6841 | Rhodiolin | Inhibitor | 98% | Unkown |
| HY-156027 | SIRT6-IN-3 | Inhibitor | 98.19% | Unkown |
| HY-176166 | PD-M6 | Degrader | 98.17% | Unkown |
| HY-N2303 | Eriocalyxin B | Inhibitor | 99.93% | Unkown |
| HY-118717 | mTOR inhibitor WYE-28 | Inhibitor | 99.75% | Unkown |
| HY-N10303 | Withangulatin A | Inhibitor | 99.76% | Unkown |
| HY-10812 | GNE-490 | Inhibitor | 96.79% | Unkown |
| HY-124582 | NEO214 | Activator | 98.0% | Unkown |
| HY-P10323A | T7 Peptide TFA | Inhibitor | 98.20% | Unkown |
| HY-171047 | Autophagy inducer 7 | Inhibitor | 99.45% | Unkown |
| HY-N6896 | Isoviolanthin | Inhibitor | 99.87% | Unkown |
| HY-N9942 | Physalin A | Inhibitor | 99.63% | Unkown |
| HY-15271 | WYE-687 | Inhibitor | 98.05% | Unkown |
| HY-101349 | L 741742 | Inhibitor | 99.28% | Unkown |
| HY-N6932 | Voacamine | 99.64% | Unkown | |
| HY-N0390S3 | L-Glutamine-13C5,15N2,d5 | Inhibitor | 99.91% | Unkown |
| HY-N0486S4 | L-Leucine-d7 | Activator | 99.91% | Unkown |
| HY-Y0106 | 2,6-Dihydroxyacetophenone | Inhibitor | 99.85% | Unkown |
| HY-N2911 | Auriculasin | Inhibitor | 98.58% | Unkown |
| HY-N5136 | 25(R,S)-Ruscogenin | Inhibitor | 99.83% | Unkown |
| HY-N11709 | Theasaponin E1 | Inhibitor | 98.68% | Unkown |
| HY-121811 | Pongamol | Inhibitor | 99.81% | Unkown |
| HY-N0143A | Phlorizin dihydrate | Inhibitor | 99.51% | Unkown |
| HY-N2000 | Bellidifolin | Modulator | 99.74% | Unkown |
| HY-N2896 | Arjunolic acid | Activator | 98.83% | Unkown |
| HY-137996 | Dehydrovomifoliol | Inhibitor | 98.88% | Unkown |
| HY-122949 | Momordicine I | Inhibitor | 97.0% | Unkown |
| HY-10219S1 | Rapamycin-13C,d3 | Inhibitor | 97.05% | Unkown |
| HY-101776A | Desmethyl-VS-5584 hydrochloride | Inhibitor | 98.63% | Unkown |
| HY-175751 | LRK-4189 | Modulator | / | Unkown |
| HY-172423 | Darlifarnib | Inhibitor | / | Unkown |
| HY-10681S | Gedatolisib-d8 | / | Unkown | |
| HY-N0486S10 | L-Leucine-18O2 | Activator | 98% | Unkown |
| HY-N12124 | Monascuspiloin | Inhibitor | 95% | Unkown |
| HY-175751A | (Rac)-LRK-4189 | Inhibitor | 96.68% | Unkown |
| HY-176761 | NSC647889 | Inhibitor | 99.28% | Unkown |
| HY-15269 | PP30 | Inhibitor | 98.01% | Unkown |
| HY-153120A | PI3K/mTOR Inhibitor-13 sodium | Inhibitor | 98.11% | Unkown |
| HY-10620 | PI3K-IN-22 | Inhibitor | 99.50% | Unkown |
| HY-141805 | MHY-1685 | Inhibitor | 99.84% | Unkown |
| HY-12652 | AZD3147 | Inhibitor | 99.93% | Unkown |
| HY-N0486S12 | L-Leucine-d2 | Activator | 99.81% | Unkown |
| HY-W654330 | Pyraclostrobin-d6 | 99.90% | Unkown | |
| HY-125953 | Ceramide (Egg) | 99% | Unkown | |
| HY-131686A | Ganglioside GT1b (porcine) ammonium | Activator | 98% | Unkown |
| HY-174066 | SI-W052 | Inhibitor | 98.0% | Unkown |
| HY-110109 | ETP-45658 | Inhibitor | 98.97% | Unkown |
| HY-156671A | RMC-4998 formic | Inhibitor | 99.02% | Unkown |
| HY-155066 | FD274 | Inhibitor | 99.45% | Unkown |
| HY-114267 | Cbz-B3A | Inhibitor | 98.63% | Unkown |
| HY-147284 | PI3K-IN-37 | Inhibitor | 99.0% | Unkown |
| HY-180261 | GP262 | Degrader | 98.43% | Unkown |
| HY-169960 | 2DII | Inhibitor | 98.92% | Unkown |
| HY-N0427 | Phellodendrine | Agonist | 99.60% | Unkown |
| HY-N0486S6 | L-Leucine-2-13C,15N | Activator | 98.0% | Unkown |
| HY-N1244 | Sarmentosin | Inhibitor | 97.0% | Unkown |
| HY-50673A | Dactolisib hydrochloride | Inhibitor | 99.41% | Unkown |
| HY-B0627S | Metformin-d6 | 98.16% | Unkown | |
| HY-10071A | Y-27632 hydrochloride hydrate | Inhibitor | 99.65% | Unkown |
| HY-203618 | PI3K/mTOR ligand-1 | Ligand | 97.28% | Unkown |
| HY-N0390S7 | L-Glutamine-15N2,d5 | Inhibitor | 98% | Unkown |
| HY-N2423 | Sinigrin hydrate | Inhibitor | 99.92% | Unkown |
| HY-N2199 | Sotetsuflavone | Inhibitor | 96.75% | Unkown |
| HY-145931 | CC214-2 | Inhibitor | 98.41% | Unkown |
| HY-N3628 | Coronarin A | Inhibitor | ≥98.0% | Unkown |
| HY-122665A | HTH-01-091 TFA | Inhibitor | 99.48% | Unkown |
| HY-156432 | ALK-IN-26 | Inhibitor | 99.87% | Unkown |
| HY-P11642A | Sialorphin TFA | Inhibitor | / | Unkown |
| HY-B0298AS | Clemastine-d5 fumarate | Activator | 99.79% | Unkown |
| HY-P3072 | Mastoparan 17 | Control | 98.09% | Unkown |
| HY-W779800 | D-α-Hydroxyglutaric acid-13C5 disodium | Inhibitor | 98.87% | Unkown |
| HY-N6651 | Isocryptotanshinone | Inhibitor | ≥98.0% | Unkown |
| HY-RS08810 | MTOR Human Pre-designed siRNA Set A | Inhibitor | / | Unkown |
| HY-N2517 | Dihydroevocarpine | Inhibitor | 99.62% | Unkown |
| HY-109633A | PI3K/mTOR-IN-23 dihydrochloride | Inhibitor | 99.70% | Unkown |
| HY-123849 | SN32976 | Inhibitor | 99.49% | Unkown |
| HY-109633 | PI3K/mTOR-IN-23 | Inhibitor | 99.0% | Unkown |
| HY-P11162 | FGF7p | Inhibitor | 99.34% | Unkown |
| HY-15271A | WYE-687 dihydrochloride | Inhibitor | ≥98.0% | Unkown |
| HY-W073128 | Perfluorotetradecanoic acid | Activator | 98.0% | Unkown |
| HY-W114419 | Bisphenol C | Inhibitor | ≥98.0% | Unkown |
| HY-N7521 | Procyanidin C2 | Inhibitor | / | Unkown |
| HY-15872 | FTI-277 | Inhibitor | / | Unkown |
| HY-U00326 | PI3Kα/mTOR-IN-1 | Inhibitor | 99.30% | Unkown |
| HY-W078733 | (S)-2-Amino-4,4,4-trifluorobutanoic acid | Modulator | ≥98.0% | Unkown |
| HY-15174R | Dactolisib Tosylate (Standard) | Inhibitor | 98.95% | Unkown |
| HY-111065 | OXA-01 | Inhibitor | / | Unkown |
| HY-115507 | NMac1 | Inhibitor | / | Unkown |
| HY-112602 | PI3K/mTOR Inhibitor-1 | Inhibitor | / | Unkown |
| HY-151137 | HSP90/mTOR-IN-1 | Inhibitor | / | Unkown |
| HY-15691 | PF-04455242 | Activator | / | Unkown |
| HY-10357 | MK-2206 free base | Inhibitor | / | Unkown |
| HY-111370 | mTOR inhibitor-2 | Inhibitor | / | Unkown |
| HY-150108 | RMC-4745 | Inhibitor | / | Unkown |
| HY-180853 | PI3K/Akt/mTOR-IN-6 | Inhibitor | / | Unkown |
| HY-149717 | Antitumor agent-122 | / | Unkown | |
| HY-16728A | Rapastinel acetate | Activator | / | Unkown |
| HY-179457 | CC-11 | Inhibitor | / | Unkown |
| HY-N0404R | Sinigrin (Standard) | Inhibitor | / | Unkown |
| HY-50876A | Daporinad hydrochloride | Inhibitor | / | Unkown |
| HY-168609 | CRI9 | Inhibitor | / | Unkown |
| HY-16397AS | Phenformin-d5 hydrochloride | Inhibitor | / | Unkown |
| HY-112537S2 | D-Glucose 6-phosphate-13C | Activator | / | Unkown |
| HY-162993 | HN2210 | Inhibitor | / | Unkown |
| HY-150061 | NVP-BBD130 | Inhibitor | / | Unkown |
| HY-P5984A | Thioether-cyclized helix B peptide, CHBP TFA | Inhibitor | / | Unkown |
| HY-184166 | COH-17 | Inhibitor | / | Unkown |
| HY-172964 | KIM-161 | Inhibitor | / | Unkown |
| HY-183250 | eALM1137 | Inhibitor | / | Unkown |
| HY-N3000A | 6-Methoxydihydrosanguinarine hydrochloride | Inhibitor | / | Unkown |
| HY-181650 | T133 | Inhibitor | / | Unkown |
| HY-W742805 | Sulindac Sulfone-d6 | / | Unkown | |
| HY-W783478 | Calebin A | Inhibitor | 98.0% | Unkown |
| HY-101349A | L 741742 hydrochloride | Inhibitor | / | Unkown |
| HY-179623 | PI3Kα-IN-29 | Inhibitor | / | Unkown |
| HY-159577 | Nic-15 | Modulator | / | Unkown |
| HY-178812 | PI3Kα-IN-27 | Inhibitor | / | Unkown |
| HY-118704 | P-2281 | Inhibitor | 99.81% | Unkown |
| HY-174855 | PI3K/mTOR-IN-17 | Inhibitor | / | Unkown |
| HY-168333 | 5-HT6 inverse agonist 1 | Inhibitor | / | Unkown |
| HY-N15121 | 4-O-Methyl-ascochlorin | Inhibitor | / | Unkown |
| HY-147913 | PI3K/Akt/mTOR-IN-3 | Inhibitor | / | Unkown |
| HY-W800535 | Cryptolepine | Inhibitor | / | Unkown |
| HY-16769 | Panulisib | Inhibitor | / | Unkown |
| HY-161856 | Antifungal agent 106 | Inhibitor | / | Unkown |
| HY-154910 | CC214-1 | Inhibitor | 98.49% | Unkown |
| HY-181059 | AMPK/mTOR modulator-1 | Inhibitor | / | Unkown |
| HY-15281 | QL-IX-55 | Inhibitor | / | Unkown |
| HY-147966 | HDAC-IN-43 | Inhibitor | / | Unkown |
| HY-10681S1 | Gedatolisib-d6 | Inhibitor | / | Unkown |
| HY-155721 | 22-(4′-py)-JA | Inhibitor | / | Unkown |
| HY-17654 | BIEGi-1 | Inhibitor | / | Unkown |
| HY-181097 | EGFR-IN-192 | Inhibitor | / | Unkown |
| HY-178192 | mTORC1-IN-3 | Inhibitor | / | Unkown |
| HY-15268 | PP487 | Inhibitor | / | Unkown |
| HY-176435 | mTOR inhibitor-28 | Inhibitor | / | Unkown |
| HY-14794AS | Levomilnacipran-d10 hydrochloride | Activator | / | Unkown |
| HY-146200 | PI3K/mTOR Inhibitor-8 | Inhibitor | / | Unkown |
| HY-N1338 | Royleanone | Inhibitor | / | Unkown |
| HY-179003 | mTOR/GLS1-IN-1 | Inhibitor | / | Unkown |
| HY-173493 | ALK-IN-31 | Inhibitor | / | Unkown |
| HY-181099 | EGFR WT/T790M-IN-4 | Inhibitor | / | Unkown |
| HY-181670 | WH23 | Inhibitor | / | Unkown |
| HY-121726 | 3HOI-BA-01 | Inhibitor | / | Unkown |
| HY-117435 | CIDD 0067106 | Inhibitor | / | Unkown |
| HY-N0486S13 | L-Leucine-15N,d10 | / | Unkown | |
| HY-P11642 | Sialorphin | Inhibitor | / | Unkown |
| HY-W765245 | Rapamycin-13C,d3-1 | Inhibitor | / | Unkown |
| HY-108959 | D-87503 | Inhibitor | / | Unkown |
| HY-101776 | Desmethyl-VS-5584 | Inhibitor | / | Unkown |
| HY-155376 | mTOR inhibitor-14 | Inhibitor | / | Unkown |
| HY-152238 | PI3K/mTOR Inhibitor-12 | Inhibitor | / | Unkown |
| HY-130133 | DHW-221 | Inhibitor | / | Unkown |
| HY-181020 | Deltafluorine | Inhibitor | / | Unkown |
| HY-183327 | PI3K/mTOR-IN-22 | Inhibitor | / | Unkown |
| HY-181710 | LASSBio-2337 | Inhibitor | / | Unkown |
| HY-172678 | PUC-10 | Inhibitor | / | Unkown |
| HY-141476 | PI3K/mTOR Inhibitor-3 | Inhibitor | / | Unkown |
| HY-170670 | DQ661 | Inhibitor | / | Unkown |
| HY-151915 | ATR-IN-20 | Inhibitor | / | Unkown |
| HY-172789 | mTOR inhibitor-27 | Inhibitor | / | Unkown |
| HY-15901 | LGB321 | Inhibitor | / | Unkown |
| HY-118160 | PPM-18 | Inhibitor | 99.17% | Unkown |
| HY-170656 | PI3K/mTOR Inhibitor-17 | Inhibitor | / | Unkown |
| HY-156445 | PI3K/mTOR Inhibitor-14 | Inhibitor | / | Unkown |
| HY-179388 | PROTAC Sirt2 Degrader-2 | Inhibitor | / | Unkown |
| HY-154958 | mTOR inhibitor-12 | Inhibitor | / | Unkown |
| HY-108338 | PF-05139962 | Inhibitor | / | Unkown |
| HY-183272 | PI3K/Akt/mTOR-IN-7 | Inhibitor | / | Unkown |
| HY-N0486S7 | L-Leucine-1-13C,15N | Activator | 99.93% | Unkown |
| HY-169022 | 4-FPBUA | Inhibitor | / | Unkown |
| HY-15901A | LGB321 monohydrochloride | Inhibitor | / | Unkown |
| HY-180056 | CAII-IN-12 | Inhibitor | / | Unkown |
| HY-144686 | ATM Inhibitor-3 | Inhibitor | / | Unkown |
| HY-137315S | TML-6-d3 | / | Unkown | |
| HY-174379 | KRAS IN-44 | Inhibitor | / | Unkown |
| HY-128027 | eCF309 | Inhibitor | 98.2% | Unkown |
| HY-161857 | Akt/mTOR-IN-1 | Inhibitor | / | Unkown |
| HY-P5984 | Thioether-cyclized helix B peptide, CHBP | Inhibitor | / | Unkown |
| HY-RS08812 | Mtor Rat Pre-designed siRNA Set A | Inhibitor | / | Unkown |
| HY-169407 | AKT-IN-24 | Inhibitor | / | Unkown |
| HY-183787 | PI3Kα-IN-33 | Inhibitor | / | Unkown |
| HY-170912 | Topo I/II-IN-2 | Inhibitor | / | Unkown |
| HY-179464 | CC-M-1 | Inhibitor | / | Unkown |
| HY-179502 | Anti-inflammatory agent 107 | Inhibitor | / | Unkown |
| HY-185460 | Pertuzumab-LD3 | Inhibitor | / | Unkown |
| HY-147614 | PI3K/mTOR Inhibitor-7 | Inhibitor | / | Unkown |
| HY-146016 | PI3K/mTOR Inhibitor-5 | Inhibitor | / | Unkown |
| HY-172259 | Toyaburgine | Inhibitor | / | Unkown |
| HY-159517 | PI3K/Akt/mTOR-IN-5 | Inhibitor | / | Unkown |
| HY-180556 | PI3K/mTOR-IN-20 | Inhibitor | / | Unkown |
| HY-144449 | mTOR/HDAC6-IN-1 | Inhibitor | / | Unkown |
| HY-N2217R | Rotundic acid (Standard) | Inhibitor | / | Unkown |
| HY-156671B | RMC-4998 TFA | Inhibitor | 99.02% | Unkown |
| HY-181491 | Tubulin-IN-64 | Inhibitor | / | Unkown |
| HY-173367 | Anticancer agent 271 | Inhibitor | / | Unkown |
| HY-183631 | PM54-1 | Inhibitor | / | Unkown |
| HY-179032 | VEGFR-2-IN-77 | Inhibitor | / | Unkown |
| HY-10116 | PI-540 | Inhibitor | / | Unkown |
| HY-184282 | Mitochondrial complex I-IN-1 | Inhibitor | / | Unkown |
| HY-N0486S5 | L-Leucine-2-13C | Activator | 98% | Unkown |
| HY-N0486S11 | L-Leucine-d1 | Activator | / | Unkown |
| HY-163511 | PI3K/Akt/mTOR-IN-4 | Inhibitor | / | Unkown |
| HY-112774A | ICSN3250 hydrochloride | Inhibitor | / | Unkown |
| HY-179155 | PI3K/mTOR-IN-19 | Inhibitor | / | Unkown |
| HY-182048 | PD-1/PD-L1-IN-62 | Modulator | / | Unkown |
| HY-168129 | GSK3β/mTOR modulator 1 | Inhibitor | / | Unkown |
| HY-178431 | MT-44 | Inhibitor | / | Unkown |
| HY-115869 | RMC-4529 | Inhibitor | / | Unkown |
| HY-B0168BS | Levomilnacipran-d5 hydrochloride | Activator | / | Unkown |
| HY-141701 | mTOR/HDAC-IN-1 | Inhibitor | / | Unkown |
| HY-120406 | PLS-123 | Inhibitor | / | Unkown |
| HY-168884 | AV457 | Inhibitor | / | Unkown |
| HY-139832 | MCX 28 | Inhibitor | / | Unkown |
| HY-178362 | CAII/VII-IN-1 | Inhibitor | / | Unkown |
| HY-173141 | mTOR inhibitor-26 | Inhibitor | / | Unkown |
| HY-122352 | OSU-03013 | Inhibitor | / | Unkown |
| HY-172175 | HYS-072 | Inhibitor | / | Unkown |
| HY-144295 | PI3Kα-IN-5 | Inhibitor | / | Unkown |
| HY-184167 | COH-19 | Inhibitor | / | Unkown |
| HY-RS08811 | Mtor Mouse Pre-designed siRNA Set A | Inhibitor | / | Unkown |
| HY-170405 | YB-3–17 | Inhibitor | / | Unkown |
| HY-P11656 | α-Neoendorphin (porcine) | Modulator | / | Unkown |
| HY-112774 | ICSN3250 | Inhibitor | / | Unkown |
| HY-172889 | PI3K/HDAC-IN-4 | Inhibitor | / | Unkown |
| HY-147285 | PI3K/mTOR Inhibitor-9 | Inhibitor | / | Unkown |
| HY-13847 | GNE-555 | Inhibitor | / | Unkown |
| HY-N13338 | Avicin D | Inhibitor | / | Unkown |
| HY-125535 | OSU-53 | Inhibitor | / | Unkown |
| HY-W142432S | Perfluoroundecanoic acid-13C7 | / | Unkown | |
| HY-161509 | PT-88 | Inhibitor | / | Unkown |
| HY-P10833 | C-VGB3 | Inhibitor | / | Unkown |
| HY-177092 | AGF347 | Inhibitor | / | Unkown |
| HY-W550739 | Acesulfame | Modulator | / | Unkown |
| HY-117767 | CZ830 | Inhibitor | / | Unkown |
| HY-112537A | D-Glucose 6-phosphate dipotassium | Activator | / | Unkown |
| HY-P10992 | YVPGP | Inhibitor | / | Unkown |
| HY-D0195R | Acesulfame potassium (Standard) | Modulator | 99.89% | Unkown |
| HY-147613 | PI3K/mTOR Inhibitor-6 | Inhibitor | / | Unkown |
| HY-162147 | Nur77 modulator 3 | Inhibitor | 99.01% | Unkown |
| HY-P10323 | T7 Peptide | Inhibitor | / | Unkown |
| HY-153120 | PI3K/mTOR Inhibitor-13 | Inhibitor | / | Unkown |
| HY-183306 | mTOR/STAT3-IN-1 | Inhibitor | / | Unkown |
| HY-18953 | mTOR inhibitor-23 | Inhibitor | / | Unkown |
| HY-144687 | ATM Inhibitor-4 | Inhibitor | / | Unkown |
| HY-160548 | mTOR inhibitor-18 | Inhibitor | / | Unkown |
| HY-176948 | M-1111 | Inhibitor | / | Unkown |
| HY-N1255A | Scoulerine hydrochloride | Inhibitor | / | Unkown |
| HY-18203 | HBF-0079 | / | Unkown | |
| HY-172816 | Carbonic anhydrase inhibitor 32 | Inhibitor | / | Unkown |
| HY-168893 | K882 | Inhibitor | / | Unkown |
| HY-176854 | PI3K/mTOR-IN-18 | Inhibitor | / | Unkown |
| HY-154957 | mTOR inhibitor-11 | Inhibitor | / | Unkown |
| HY-127067 | Yuanhuadin | Inhibitor | / | Unkown |
| HY-N0390G | L-Glutamine (GMP) | Inhibitor | / | Unkown |
| HY-N6626R | Pyraclostrobin (Standard) | / | Unkown | |
| HY-175220 | 4-TCPA | Inhibitor | / | Unkown |
| HY-169100 | Antiproliferative agent-57 | / | Unkown | |
| HY-174141 | LP-65 | Inhibitor | / | Unkown |
| HY-183307 | mTOR-IN-29 | Inhibitor | / | Unkown |
| HY-174382 | ROR1-IN-3 | Inhibitor | / | Unkown |
| HY-119831 | Rohitukine | Inhibitor | / | Unkown |
| HY-W339757 | Dioctanoylphosphatidic acid sodium | / | Unkown | |
| HY-181925 | FD2024 | Inhibitor | / | Unkown |
| HY-138976 | NV-5440 | Inhibitor | / | Unkown |
| HY-168919 | KRASG12C IN-16 | Inhibitor | / | Unkown |
| HY-N0112S | Dihydromyricetin-d4 | Inhibitor | / | Unkown |
| HY-N15267 | Ovalitenone | Inhibitor | / | Unkown |
| HY-162024 | mTOR inhibitor-16 | Inhibitor | / | Unkown |
| HY-171229 | 1-Acetyl-DHAP | Substrate | / | Unkown |
| HY-Y0252S8 | L-Proline-d4 | Activator | / | Unkown |
| HY-110038 | FTI-277 TFA | Inhibitor | / | Unkown |
| HY-162025 | mTOR inhibitor-17 | Inhibitor | / | Unkown |
| HY-164662 | mTOR inhibitor-24 | Inhibitor | / | Unkown |
| HY-162023 | mTOR inhibitor-10 | Inhibitor | / | Unkown |
| HY-112903A | YW3-56 hydrochloride | Inhibitor | / | Unkown |
| HY-164384 | DFX117 | Inhibitor | / | Unkown |
| HY-185456 | PI3K/mTOR-IN-21 | Inhibitor | / | Unkown |
| HY-180936 | FBPase-IN-6 | Modulator | / | Unkown |
| HY-156484 | SPR519 | Inhibitor | / | Unkown |
| HY-N12531 | Molephantin | Inhibitor | / | Unkown |
| HY-N1677R | 2,6-Dimethoxy-1,4-benzoquinone (Standard) | / | Unkown | |
| HY-N0819R | Raddeanin A (Standard) | / | Unkown | |
| HY-N10133 | Licoflavanone | Inhibitor | / | Unkown |
| HY-N0143R | Phlorizin (Standard) | Inhibitor | / | Unkown |
| HY-155211 | mTOR inhibitor-13 | Inhibitor | / | Unkown |
| HY-W780189 | (rac)-Monepantel | Inhibitor | 99.87% | Unkown |
| HY-164385 | NSC126405 | Inhibitor | 99.20% | Unkown |
| HY-Y1177R | Diphenyl disulfide (Standard) | Inhibitor | / | Unkown |
| HY-W019868 | 1-O-Hexadecyl-2-O-acetyl-sn-glycerol | Inhibitor | / | Unkown |
| HY-10218S1 | Everolimus-13C2,d4 | Inhibitor | / | Unkown |
| HY-134922 | NS1-IN-1 | Inhibitor | / | Unkown |
| HY-N10379 | 19-epi-Scholaricine | Inhibitor | 99.14% | Unkown |
| HY-N6926 | 1,3,5-Tricaffeoylquinic acid | Inhibitor | / | Unkown |
| HY-117923 | PF-06465603 | Inhibitor | / | Unkown |
| HY-N0836A | Jervine hydriodide | Inhibitor | / | Unkown |
| HY-116191 | WJD008 | Inhibitor | / | Unkown |
| HY-N10754 | Aschantin | Inhibitor | / | Unkown |
| HY-W781875 | Sirolimus isomer C | / | Unkown | |
| HY-155475 | mTORC1-IN-2 | Inhibitor | / | Unkown |
| HY-W419331 | Methionyl-methionine | Activator | / | Unkown |
| HY-19896A | COTI-2 hydrochloride | Inhibitor | / | Unkown |
| HY-185457 | BrAC-GGFG-Aminal-PI3K/mTOR-IN-21 | Inhibitor | / | Unkown |
| HY-W074912 | (S)-2-Amino-5,5,5-trifluoropentanoic acid | Inhibitor | / | Unkown |
| HY-B0627S1 | Metformin-13C2 hydrochloride | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(3)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-P992201 | Anti-CD160 Antibody (MAT 302) | Activator | / | Unkown |
| HY-P990248 | Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) | Inhibitor | / | Unkown |
| HY-P992392 | JM1-24-3 | Inhibitor | / | Unkown |